| Ms Jennifer E Knight, LCSW | |
|
102 Winston Way Ste A, Campbellsville, KY 42718-4953 | |
| (270) 215-2373 | |
| (888) 975-1981 |
| Full Name | Ms Jennifer E Knight |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 24 Years |
| Location | 102 Winston Way Ste A, Campbellsville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306269139 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1771 (Kentucky) | Primary |
| Entity Name | Mental Health & Wellness Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548779556 PECOS PAC ID: 6709143316 Enrollment ID: O20171206000649 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Percepta Associates Inc. announces the release of Series Three of its Gene Expression Profiling Life Science Dashboard market research report. Unique to the Percepta report, Series Three offers comparisons to the findings of Series One (February 2007) and Series Two (April 2008).
Researchers are being urged to differentiate between two types of bladder cancer when they carry out studies, after a detailed trends analysis revealed significant differences between the main subtypes of the disease.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer E Knight, LCSW 102 Winston Way Ste A, Campbellsville, KY 42718-4953 Ph: (270) 215-2373 | Ms Jennifer E Knight, LCSW 102 Winston Way Ste A, Campbellsville, KY 42718-4953 Ph: (270) 215-2373 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Percepta Associates Inc. announces the release of Series Three of its Gene Expression Profiling Life Science Dashboard market research report. Unique to the Percepta report, Series Three offers comparisons to the findings of Series One (February 2007) and Series Two (April 2008).
Researchers are being urged to differentiate between two types of bladder cancer when they carry out studies, after a detailed trends analysis revealed significant differences between the main subtypes of the disease.
GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.
Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has signed a contract valued at up to $153 million over five years with the Biomedical Advanced Research and Development Authority (BARDA) in the Office of the Assistant Secretary for Preparedness and Response of the Department of Health and Human Services, to develop CLT-008, a cellular therapy for the treatment of Acute Radiation Syndrome (ARS).
› Verified 5 days ago
Heather Brook Graham, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 50 Gene Cash Rd, Campbellsville, KY 42718 Phone: 270-465-7768 | |
Tammy Lynn Thrasher, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 830 W Broadway St, Campbellsville, KY 42718 Phone: 833-510-4357 Fax: 866-459-6532 | |
Heather M Akin, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 50 Gene Cash Rd, Campbellsville, KY 42718 Phone: 270-465-7688 | |
Sarah Elizabeth Hayes, MSW, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 Winston Way Ste 3, Campbellsville, KY 42718 Phone: 270-465-0078 | |
Denise Taylor, CSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3020 Old Lebanon Rd, Campbellsville, KY 42718 Phone: 270-465-7424 Fax: 270-465-7993 | |
Mrs. Kayla Dawn Beasley, MSW, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 102 Winston Way Ste 3, Campbellsville, KY 42718 Phone: 270-465-0078 |